Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

March 2030 31

  1. Study completion A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07788989

  2. Study completion ArcFlex Sheath in TAVR Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07320274

  3. Study completion Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05027984

  4. Study completion MOTIV BTK Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05406622

  5. Primary completion Gathering Evidence on Best Practices for Lay Rescuer CPR Training Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05908500

  6. Study completion Empagliflozin Treatment in Kidney Transplant Recipients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06013865

  7. Primary completion Empagliflozin Treatment in Kidney Transplant Recipients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06013865

  8. Study completion Pivotal Trial of the Boomerang Catheter for pDVA Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06311773

  9. Study completion Effect of Dotinurad in Hyperuricemia With Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06834230

  10. Study completion Metabolic Surgery for Atrial Fibrillation Elimination Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07027969

April 2030 9

  1. Study completion MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06269692

  2. Primary completion MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06269692

  3. Primary completion A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07419828

  4. Study completion Colchicine in Chronic Limb-Threatening Ischemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07536373

  5. Study completion Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07115953

  6. Study completion Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07342608

  7. Study completion Comparison of Available Standard Pulse Field Ablation Methods for Pulmonary Vein Isolation for Treatment of Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07456540

  8. Primary completion Comparison of Available Standard Pulse Field Ablation Methods for Pulmonary Vein Isolation for Treatment of Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07456540

  9. Study completion Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07746271

May 2030 14

  1. Primary completion Exploring Motor Learning in Acute Stroke Through Robotics Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04171856

  2. Primary completion inDividual, Targeted thrombosIS Prophylaxis Versus the Standard One Size Fits All Approach in Patients Undergoing Total hIp or Total kNee replaCemenT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06581965

  3. Study completion Complex Abdominal Aortic Aneurysm Repair With Fenestrated Stent Grafts Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01937949

  4. Study completion Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03176186

  5. Study completion MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05409989

  6. Study completion Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05569772

  7. Study completion A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07419828

  8. Study completion REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07410117

  9. Study completion A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07625215

  10. Primary completion A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07625215

  11. Primary completion TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07052903

  12. Study completion Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05373940

  13. Primary completion Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05373940

  14. Primary completion Neuromodulation for Metabolic Dysfunction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07597161

June 2030 35

  1. Primary completion A Polypill for Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07032389

  2. Study completion Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07356284

  3. Primary completion Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07356284

  4. Study completion Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07736196

  5. Study completion Recombinant Human Prourokinase for Acute Ischemic Stroke in the Extended Window Selected by CT-Based Artificial Intelligence Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07901842

  6. Study completion Artificial Intelligence-enabled Management of Atrial Fibrillation(ABLE-AF Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07938281

  7. Study completion Retina is a Marker for Cerebrovascular Heath Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04753970

  8. Primary completion Retina is a Marker for Cerebrovascular Heath Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04753970

  9. Study completion Pilot/Pivotal Study of DBS+Rehab After Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05701280

  10. Study completion Telerehabilitation In The Home After Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06682429

  11. Primary completion Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07084259

  12. Study completion Noninvasive CA Monitoring Validation and Autonomic Modulation in Aneurysmal Subarachnoid Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07577739

  13. Primary completion A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07680829

  14. Study completion Superiority Trial of Aphasia-focused Rehabilitation With tDCS Stimulation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07688551

  15. Study completion Personalized Antiplatelet Therapy to Prevent Recurrent Cardiovascular Events in After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07943026

  16. Study completion Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT00117936

  17. Study completion Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07735130

  18. Primary completion Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07735130

  19. Study completion TRISCEND II Pivotal Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04482062

  20. Study completion China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04974138

  21. Primary completion China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04974138

  22. Study completion INSIGHTFUL-FFR Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05437900

  23. Study completion High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05845424

  24. Study completion Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06360458

  25. Study completion Stroke Prevention in Nigeria 2 Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06526117

  26. Primary completion Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07210606

  27. Study completion Ultralow Dose PET Imaging of 18F-flurpiridaz Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07284576

  28. Primary completion Ultralow Dose PET Imaging of 18F-flurpiridaz Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07284576

  29. Primary completion FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07332741

  30. Study completion Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07349875

  31. Study completion Lithotripsy Versus Balloon Angioplasty for Optimal Treatment of CAlcified Lesions With and Without Optical Coherence Tomography evaluatION Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07388030

  32. Study completion OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07576257

  33. Primary completion Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07632898

  34. Study completion Flow Diverter Versus Conventional Endovascular Treatment for Unruptured Wide-Neck Bifurcation Aneurysms (FD-BWA Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07707076

July 2030 20

  1. Study completion A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07624305

  2. Primary completion A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07624305

  3. Study completion Proton Radiotherapy for Primary Central Nervous System Tumours in Adults Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02797366

  4. Study completion ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03517436

  5. Primary completion Incremental Hemodialysis: The TwoPlus Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05828823

  6. Study completion Impact GLP-1 Agonists Following Bariatric Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06132477

  7. Study completion Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07084259

  8. Study completion Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07442071

  9. Primary completion Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07442071

  10. Study completion Pentoxifylline in Diabetic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03625648

  11. Primary completion Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04684602

  12. Study completion UBT251 Injection Phase II Clinical Study (CKD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07134335

  13. Primary completion UBT251 Injection Phase II Clinical Study (CKD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07134335

  14. Study completion Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06291376

  15. Primary completion Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07770282

  16. Primary completion Heart Rate Regularization in Atrial Fibrilation and Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05029570

  17. Study completion Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries (StratMed-MINOCA) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05198791

  18. Study completion FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06409364

  19. Study completion A Polypill for Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07032389

  20. Primary completion RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07696975

August 2030 13

  1. Study completion Investigation of the NVT ALLEGRA Plus THV System in Patients With Severe Aortic Stenosis or Failed Surgical Aortic Bioprosthesis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05804903

  2. Study completion Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06440707

  3. Study completion kTMP in Chronic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07277595

  4. Primary completion kTMP in Chronic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07277595

  5. Primary completion Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07238972

  6. Primary completion Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07695701

  7. Study completion Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07754318

  8. Study completion LuX-Valve Plus System for Severe or Greater Tricuspid Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07705594

  9. Primary completion A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07821957

  10. Study completion Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04893291

  11. Study completion ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05686317

  12. Study completion Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07108985

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices Registry record

    Expected 2026-02-01; that period ended on 2026-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06652750

  2. Primary completion Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease Registry record

    Expected 2026-02-01; that period ended on 2026-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07180745

  3. Study start Efficacy of Montelukast on STEMl Patients Registry record

    Expected 2026-02-01; that period ended on 2026-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07320625

  4. Study start Combined Mitral and Tricuspid Versus Isolated Mitral Transcatheter Edge-to-Edge Repair for Mitral Regurgitation With Tricuspid Regurgitation (DUAL-TEER Trial) Registry record

    Expected 2026-02-01; that period ended on 2026-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07349888

  5. Study start VR Training to Improve Postoperative Cognitive Function in Elderly Patients With Cerebral Small Vessel Disease Undergoing Non-Cardiac Surgery Registry record

    Expected 2026-02-01; that period ended on 2026-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07370844

  6. Study start Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes Registry record

    Expected 2026-02-01; that period ended on 2026-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07383155

  7. Study start DNV001 Injection in Patients With Hypercholesterolemia Registry record

    Expected 2026-02-05; that period ended on 2026-02-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07391722

  8. Study start The Coronary Sinus Balloon Pump in STEMI Registry record

    Expected 2026-02-12; that period ended on 2026-02-12.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07354035

  9. Study start Comparison of Available Standard Pulse Field Ablation Methods for Pulmonary Vein Isolation for Treatment of Atrial Fibrillation Registry record

    Expected 2026-02-15; that period ended on 2026-02-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07456540

  10. Primary completion To Evaluate the Safety and Efficacy of Intracranial Stent Assisted Endovascular Treatment of Intracranial Aneurysms Registry record

    Expected 2026-02-20; that period ended on 2026-02-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06158087

  11. Primary completion Coronary Aspiration Catheter Clinical Trial Registry record

    Expected 2026-02-20; that period ended on 2026-02-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06951724

  12. Study start A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone Registry record

    Expected 2026-02-24; that period ended on 2026-02-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07394114

  13. Study completion Preventing Hypoxia in Sedated TAVI: SuperNO₂VA vs. Conventional Oxygen Registry record

    Expected 2026-02-25; that period ended on 2026-02-25.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07006064

  14. Study completion Social Determinants and a Diabetes Prevention Program Tailored for African Americans Registry record

    Expected 2026-02-28; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05301413

  15. Study completion Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants Registry record

    Expected 2026-02-28; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05547165

  16. Primary completion Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants Registry record

    Expected 2026-02-28; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05547165

  17. Study completion Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05825573

  18. Study completion Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension Registry record

    Expected 2026-02-28; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06041529

  19. Primary completion Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension Registry record

    Expected 2026-02-28; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06041529

  20. Primary completion To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms Registry record

    Expected 2026-02-28; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06158750

  21. Primary completion FibriCheck Data Registry Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06282393

  22. Primary completion Evaluation of the Efficacy and Safety of Surgical Device Lymphoblock for Prevention of Lymphorrhea in Patients With Thoracoabdominal Aorta Repair. Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06286540

  23. Study completion A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06559722

  24. Primary completion A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06568471

  25. Study completion WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06752772

  26. Study completion Impact of CYP2C19 Genotype-guided Approach in Antiplatelet Therapy on Platelet Reactivity Index Among Coronary Artery Disease (CAD) Patients Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06759272

  27. Primary completion Impact of CYP2C19 Genotype-guided Approach in Antiplatelet Therapy on Platelet Reactivity Index Among Coronary Artery Disease (CAD) Patients Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06759272

  28. Primary completion A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07018453

  29. Study completion Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension Registry record

    Expected 2026-02-28; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07064525

  30. Study completion A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin Registry record

    Expected 2026-02-28; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07109700

  31. Study completion FAPO-2: Cardiac Patient Monitoring Tool for Clinical Observation and Arrhythmia Detection Registry record

    Expected 2026-02-28; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07174206

  32. Study start Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07181382

  33. Study start HEARTS in Sync + CardioWatch 287-2 Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07322510

  34. Study start Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE II) Registry record

    Expected 2026-02-28; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07343076

  35. Study start ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07371689

  36. Study start Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07380919

  37. Study start Reversal to Normoglycemia by Treating Prediabetes Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07392151

  38. Study start Effect of Add-on L-Arginine Therapy on Heart Failure Patients Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07394270

  39. Study start Safety and Efficacy of the RENATUS® Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07414342

  40. Study start Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR Registry record

    Expected 2026-02; that period ended on 2026-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07434661

  41. Study completion The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03840226

  42. Primary completion Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication? Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04892199

  43. Study completion Timely Recovery After Subclinical Heart Failure Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06341101

  44. Primary completion Timely Recovery After Subclinical Heart Failure Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06341101

  45. Study completion Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-D ) Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06522282

  46. Study start Effects of Nicorandil on Microvascular Dysfunction in Patients With STEMI Undergoing Primary PCI Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06787430

  47. Primary completion Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06820567

  48. Study start Synergistic Minimally Invasive Surgery and Deferoxamine in ICH Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07162363

  49. Study completion Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07180745

  50. Study start ArcFlex Sheath in TAVR Trial Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07320274

  51. Study start Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07347626

  52. Primary completion Blended Resources for Integrated Diabetes Guidance and Empowerment Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07373379

  53. Study start Blended Resources for Integrated Diabetes Guidance and Empowerment Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07373379

  54. Study start A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07373613

  55. Study start Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07374718

  56. Study start Microwave Ablation for Treatment of Vascular Malformations: Efficacy and Safety Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07404670

  57. Study start Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD) Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07415642

  58. Study start Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07436182

  59. Study start Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07471282

  60. Study start Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window Registry record

    Expected 2026-03-01; that period ended on 2026-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07476898

  61. Study start Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease Registry record

    Expected 2026-03-02; that period ended on 2026-03-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07206290

  62. Study start QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia Registry record

    Expected 2026-03-05; that period ended on 2026-03-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07444086

  63. Study completion Thrombectomy In TANdem Occlusion Registry record

    Expected 2026-03-06; that period ended on 2026-03-06.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03978988

  64. Primary completion Aggressive Smoking Cessation Trial (ASAP) Registry record

    Expected 2026-03-07; that period ended on 2026-03-07.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05257629

  65. Study start A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire Registry record

    Expected 2026-03-14; that period ended on 2026-03-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07054541

  66. Study completion Combinating Fingolimod With Alteplase Bridging With Thrombectomy in Acute Ischemic Stroke Registry record

    Expected 2026-03-15; that period ended on 2026-03-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04675762

  67. Study start Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes Registry record

    Expected 2026-03-15; that period ended on 2026-03-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07173712

  68. Study start Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial Registry record

    Expected 2026-03-17; that period ended on 2026-03-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07449910

  69. Primary completion Combination of Hypothermia and Thrombectomy in Acute Stroke Registry record

    Expected 2026-03-18; that period ended on 2026-03-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06301412

  70. Study start Lithotripsy Versus Balloon Angioplasty for Optimal Treatment of CAlcified Lesions With and Without Optical Coherence Tomography evaluatION Registry record

    Expected 2026-03-20; that period ended on 2026-03-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07388030

  71. Study start Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial Registry record

    Expected 2026-03-20; that period ended on 2026-03-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07485075

  72. Primary completion Structural Heart Surgery Assist System for Transcatheter Mitral Valve Edge-to-Edge Repair (TEER). Registry record

    Expected 2026-03-22; that period ended on 2026-03-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07055919

  73. Study start POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure Registry record

    Expected 2026-03-23; that period ended on 2026-03-23.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07469722

  74. Study start Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO) Registry record

    Expected 2026-03-25; that period ended on 2026-03-25.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07469293

  75. Study start A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Registry record

    Expected 2026-03-27; that period ended on 2026-03-27.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07417306

  76. Study completion Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3 Registry record

    Expected 2026-03-30; that period ended on 2026-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04263922

  77. Study completion SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF Registry record

    Expected 2026-03-30; that period ended on 2026-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06442280

  78. Primary completion The Renal Protective Effects of Remote Ischemic Preconditioning in Patients With Chronic Kidney Disease Registry record

    Expected 2026-03-30; that period ended on 2026-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06501222

  79. Primary completion Nebivolol ANOCA Treatment Randomized Trial Registry record

    Expected 2026-03-30; that period ended on 2026-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06755801

  80. Study completion The Effectiveness and Safety of the Coronary Artery Serrated Cutting Balloon Dilation Catheter in the Pre-dilation of Coronary Artery Stenosis Lesions Registry record

    Expected 2026-03-30; that period ended on 2026-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06926400

  81. Study start Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II Registry record

    Expected 2026-03-30; that period ended on 2026-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07134712

  82. Primary completion A Study on the Effect of Electronic Moxibustion Based on Ziwu Liuzhu in Treating Constipation in Stroke Patients Registry record

    Expected 2026-03-30; that period ended on 2026-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07372326

  83. Study start Design and Application of a Home Care WeChat Mini-Program for Children After Congenital Heart Disease Surgery Registry record

    Expected 2026-03-30; that period ended on 2026-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07385209

  84. Primary completion Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes Registry record

    Expected 2026-03-30; that period ended on 2026-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07452913

  85. Study start Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest Registry record

    Expected 2026-03; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03176186

  86. Study completion Subcutaneous Nitroglycerin to Facilitate Trans-radial Access. Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03304496

  87. Study completion ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03462498

  88. Study completion STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03777631

  89. Primary completion STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03777631

  90. Study completion European Blood Pressure Intensive Control After Stroke Registry record

    Expected 2026-03; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04647292

  91. Study completion Long-term Beta-blocker Therapy After Acute Myocardial Infarction Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04769362

  92. Study completion Eversense® Non-adjunctive Use Post Approval Study Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04836546

  93. Primary completion Eversense® Non-adjunctive Use Post Approval Study Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04836546

  94. Study completion The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions Registry record

    Expected 2026-03; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05033964

  95. Study completion Effect of Antifibrotic Therapy on Regression of Myocardial Fibrosis After Transcatheter Aortic Valve Implantation (TAVI) in Aortic Stenosis Patients With High Fibrotic Burden Registry record

    Expected 2026-03; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05230901

  96. Primary completion CardioPulmonary Resuscitation With Argon (CPAr) Trial Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05482945

  97. Study completion Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05604638

  98. Study completion Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19 Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05619653

  99. Primary completion Transfemoral Transcatheter Aortic Valve Implementation at Hospital Without On-site Cardiac Surgery: Early Clinical Outcome in Patients With Prohibitive Surgical Risk. Registry record

    Expected 2026-03; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05886517

  100. Primary completion Smartwatches for Detection of Atrial Fibrillation (AFib) in Secondary Prevention of Cryptogenic Stroke Registry record

    Expected 2026-03; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06005233